H

Hugel Inc
KOSDAQ:145020

Watchlist Manager
Hugel Inc
KOSDAQ:145020
Watchlist
Price: 274 500 KRW 3.98%
Market Cap: 3T KRW
Have any thoughts about
Hugel Inc?
Write Note

Relative Value

The Relative Value of one Hugel Inc stock under the Base Case scenario is 254 174.77 KRW. Compared to the current market price of 274 500 KRW, Hugel Inc is Overvalued by 7%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
254 174.77 KRW
Overvaluation 7%
Relative Value
Price
H
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
20
vs Industry
49
Median 3Y
6
Median 5Y
7.3
Industry
8.1
Forward
7.2
vs History
46
vs Industry
6
Median 3Y
21.9
Median 5Y
27.8
Industry
23
Forward
24.1
vs History
20
vs Industry
8
Median 3Y
17.9
Median 5Y
21.1
Industry
23.4
vs History
55
vs Industry
6
Median 3Y
34.1
Median 5Y
45.8
Industry
27.3
vs History
0
vs Industry
22
Median 3Y
2.1
Median 5Y
2.4
Industry
2.6
vs History
12
vs Industry
44
Median 3Y
4.2
Median 5Y
5.6
Industry
8.1
Forward
6.2
vs History
15
vs Industry
37
Median 3Y
5.5
Median 5Y
7.5
Industry
9.6
vs History
17
vs Industry
6
Median 3Y
9.9
Median 5Y
13.8
Industry
4.3
Forward
14.4
vs History
17
vs Industry
5
Median 3Y
11.5
Median 5Y
15.3
Industry
3.8
Forward
15.1
vs History
9
vs Industry
8
Median 3Y
12.4
Median 5Y
15.5
Industry
6
vs History
34
vs Industry
6
Median 3Y
26.1
Median 5Y
30.1
Industry
3.8
vs History
4
vs Industry
29
Median 3Y
2.5
Median 5Y
3.6
Industry
4.8

Multiples Across Competitors

Competitors Multiples
Hugel Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
Hugel Inc
KOSDAQ:145020
2.7T KRW 8.3 25.6 15.5 17.2
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 563 478.2 -178 533.6 -216 796.7 -214 322.8
US
Abbvie Inc
NYSE:ABBV
301B USD 5.4 59.2 14.8 22.8
US
Amgen Inc
NASDAQ:AMGN
162B USD 5 38.3 17.8 33.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
127.5B USD 12 -265.7 26.9 28.2
US
Gilead Sciences Inc
NASDAQ:GILD
115.4B USD 4.1 916 10.2 10.2
US
Epizyme Inc
F:EPE
94.1B EUR 1 875.5 -478.6 -521.2 -507.3
AU
CSL Ltd
ASX:CSL
138B AUD 6 33.9 20.9 26
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
88.6B USD 6.4 19 17.5 19.4
US
Seagen Inc
F:SGT
39.3B EUR 18.1 -55.4 -59.5 -53.7
NL
argenx SE
XBRU:ARGX
34.1B EUR 18.5 -129.9 -104.5 -76.1
P/E Multiple
Earnings Growth
KR
H
Hugel Inc
KOSDAQ:145020
Average P/E: 182
25.6
85%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -178 533.6 N/A
US
Abbvie Inc
NYSE:ABBV
59.2
412%
US
Amgen Inc
NASDAQ:AMGN
38.3
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -265.7
42%
US
Gilead Sciences Inc
NASDAQ:GILD
916
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -478.6 N/A
AU
CSL Ltd
ASX:CSL
33.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -55.4 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -129.9 N/A
EV/EBITDA Multiple
EBITDA Growth
KR
H
Hugel Inc
KOSDAQ:145020
Average EV/EBITDA: 17.6
15.5
100%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 796.7 N/A
US
Abbvie Inc
NYSE:ABBV
14.8
28%
US
Amgen Inc
NASDAQ:AMGN
17.8
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.9
38%
US
Gilead Sciences Inc
NASDAQ:GILD
10.2
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -521.2 N/A
AU
CSL Ltd
ASX:CSL
20.9
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.5
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.5 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -104.5 N/A
EV/EBIT Multiple
EBIT Growth
KR
H
Hugel Inc
KOSDAQ:145020
Average EV/EBIT: 22.5
17.2
93%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -214 322.8 N/A
US
Abbvie Inc
NYSE:ABBV
22.8
88%
US
Amgen Inc
NASDAQ:AMGN
33.7
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
28.2
44%
US
Gilead Sciences Inc
NASDAQ:GILD
10.2
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -507.3 N/A
AU
CSL Ltd
ASX:CSL
26
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.4
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.1 N/A

See Also

Discover More
Back to Top